Li, Nanxin <br/><br/>
Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer.  [electronic resource] 

 -  Current medical research and opinion  Aug 2015 
 - 1573-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2015.1062358  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Androstadienes--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--chemistry<br/>Everolimus--therapeutic use<br/>Female<br/>Humans<br/>Liver Neoplasms--secondary<br/>Middle Aged<br/>Receptor, ErbB-2--analysis<br/>Receptors, Estrogen--analysis<br/>Retrospective Studies